<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rouvas, Alexandros</style></author><author><style face="normal" font="default" size="100%">Chatziralli, Irini</style></author><author><style face="normal" font="default" size="100%">Androu, Angeliki</style></author><author><style face="normal" font="default" size="100%">Mpougatsou, Panagiota</style></author><author><style face="normal" font="default" size="100%">Alonistiotis, Dimitrios</style></author><author><style face="normal" font="default" size="100%">Douvali, Maria</style></author><author><style face="normal" font="default" size="100%">Kabanarou, Stamatina A</style></author><author><style face="normal" font="default" size="100%">Theodossiadis, Panagiotis</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration</style></title><secondary-title><style face="normal" font="default" size="100%">International ophthalmology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2019</style></year></dates><number><style face="normal" font="default" size="100%">2</style></number><publisher><style face="normal" font="default" size="100%">Springer Netherlands</style></publisher><volume><style face="normal" font="default" size="100%">39</style></volume><pages><style face="normal" font="default" size="100%">431–440</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>